This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Zesteem

Inspired Capital plc

Drug Names(s): Zesteem

Description: Zesteem is a novel formulation of 17beta estradiol and has been shown to accelerate healing (re-epithelialisation) following surgery or wounding. Dose response experiments conducted by Renovo have demonstrated that the dose and formulation of estradiol required to be delivered locally in order to accelerate healing is quite specific, meaning that accurate delivery is important for human efficacy and that off-label uses of estradiol, sold in the form of creams and gels prepared in pharmacies, are highly unlikely to have the desired therapeutic effects.


Zesteem News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug